Veracyte traded at $21.97 this Friday March 24th, decreasing $0.15 or 0.68 percent since the previous trading session. Looking back, over the last four weeks, Veracyte lost 9.29 percent. Over the last 12 months, its price fell by 18.51 percent. Looking ahead, we forecast Veracyte to be priced at 21.72 by the end of this quarter and at 19.71 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
21.97
Daily Change
-0.68%
Yearly
-18.51%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agilent 131.96 0.83 0.63% -2.76%
Agenus 1.49 0.01 0.68% -44.81%
Anika Therapeutics 28.02 -0.03 -0.11% 8.39%
Arrowhead Research 24.29 0.61 2.58% -44.93%
Biocept 0.29 -0.01 -2.67% -87.02%
Bruker 75.77 0.92 1.23% 15.91%
Exact Sciences 66.28 0.87 1.33% -0.59%
Heron Therapeutics 1.91 -0.16 -7.75% -65.36%
Illumina 220.00 3.05 1.41% -35.62%
Immunogen 3.79 0.06 1.61% -11.03%
Karyopharm Therapeutics 3.32 0.10 3.11% -54.58%
Ligand Pharmaceuticals 69.38 0.62 0.90% -39.34%
Laboratory Of America 218.41 3.76 1.75% -20.28%
Myriad Genetics 23.72 0.09 0.38% -6.39%
Rigel Pharmaceuticals 1.25 -0.03 -2.34% -60.69%
Roche Holding 258.25 -0.10 -0.04% -31.08%
Sangamo BioSciences 1.66 -0.04 -2.35% -71.13%
Sonic Healthcare 33.75 -0.34 -1.00% -3.98%
Siemens 140.08 -5.10 -3.51% 9.11%
Thermo Fisher Scientific 558.26 3.07 0.55% -2.79%
Veracyte 21.97 -0.15 -0.68% -18.51%
Waters 299.96 1.79 0.60% -7.98%
Intrexon 0.96 0.02 2.44% -53.39%

Indexes Price Day Year
USND 11824 36.56 0.31% -16.55%
US2000 1735 14.63 0.85% -16.51%

Veracyte
Veracyte, Inc. is a genomic diagnostics company. The Company, through its scientific platform, which utilizes ribonucleic acid (RNA), whole-transcriptome sequencing combined with machine learning, produces genomic tests. It provides various genomic tests, including Afirma Genomic Sequencing Classifier (GSC), Percepta Bronchial Genomic Classifier, Envisia Genomic Classifier and Afirma Xpression Atlas. It provides GSC tests for thyroid cancer. It provides Percepta Bronchial Genomic Classifier tests for lung cancer. It provides Envisia Genomic Classifier tests for idiopathic pulmonary fibrosis (IPF). Its Afirma Xpression Atlas provides information on gene alterations associated with thyroid cancer, enabling physicians to tailor surgical and treatment decisions at time of diagnosis.